Deutsche Bank’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,985
| Closed | -$165K | – | 4798 |
|
|
2020
Q4 | $165K | Buy |
8,985
+2,478
| +38% | +$45.2K | ﹤0.01% | 3570 |
|
|
2020
Q3 | $119K | Buy |
6,507
+599
| +10% | +$10.1K | ﹤0.01% | 3470 |
|
|
2020
Q2 | $89K | Buy |
5,908
+1,863
| +46% | +$26.6K | ﹤0.01% | 3501 |
|
|
2020
Q1 | $64K | Sell |
4,045
-246
| -6% | -$3.98K | ﹤0.01% | 3434 |
|
|
2019
Q4 | $68K | Buy |
4,291
+871
| +25% | +$14.5K | ﹤0.01% | 3792 |
|
|
2019
Q3 | $50K | Sell |
3,420
-5,948
| -63% | -$80.2K | ﹤0.01% | 3940 |
|
|
2019
Q2 | $152K | Sell |
9,368
-5,164
| -36% | -$84.3K | ﹤0.01% | 3987 |
|
|
2019
Q1 | $250K | Sell |
14,532
-636
| -4% | -$11.5K | ﹤0.01% | 3875 |
|
|
2018
Q4 | $267K | Sell |
15,168
-12,864
| -46% | -$218K | ﹤0.01% | 3716 |
|
|
2018
Q3 | $508K | Buy |
28,032
+5,834
| +26% | +$120K | ﹤0.01% | 3775 |
|
|
2018
Q2 | $435K | Buy |
22,198
+22,167
| +71,506% | +$415K | ﹤0.01% | 3919 |
|
|
2018
Q1 | $0 | Sell |
31
-92
| -75% | -$1.68K | ﹤0.01% | 5703 |
|
|
2017
Q4 | $1K | Hold |
123
| – | – | ﹤0.01% | 4961 |
|
|
2017
Q3 | $1K | Hold |
123
| – | – | ﹤0.01% | 4841 |
|
|
2017
Q2 | $1K | Sell |
123
-2,915
| -96% | -$25.7K | ﹤0.01% | 4886 |
|
|
2017
Q1 | $35K | Sell |
3,038
-4,316
| -59% | -$52.4K | ﹤0.01% | 4339 |
|
|
2016
Q4 | $95K | Buy |
7,354
+5,262
| +252% | +$70.4K | ﹤0.01% | 4114 |
|
|
2016
Q3 | $30K | Buy |
2,092
+142
| +7% | +$2.02K | ﹤0.01% | 4409 |
|
|
2016
Q2 | $23K | Buy |
1,950
+493
| +34% | +$7.92K | ﹤0.01% | 4719 |
|
|
2016
Q1 | $26K | Sell |
1,457
-970
| -40% | -$16.1K | ﹤0.01% | 4559 |
|
|
2015
Q4 | $51K | Sell |
2,427
-288
| -11% | -$6.09K | ﹤0.01% | 4393 |
|
|
2015
Q3 | $45K | Buy |
2,715
+351
| +15% | +$8.73K | ﹤0.01% | 4508 |
|
|
2015
Q2 | $88K | Sell |
2,364
-1,136
| -32% | -$36.6K | ﹤0.01% | 4303 |
|
|
2015
Q1 | $110K | Buy |
+3,500
| New | +$94.6K | ﹤0.01% | 4084 |
|
Deutsche Bank's CBMG Position: Q1 2021 in Review
Deutsche Bank sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 8,985 shares — an estimated $165K sold.
Deutsche Bank first reported a position in CBMG in Q1 2015 and held it in 24 quarters. The position peaked at $508K in Q3 2018. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.
- Deutsche Bank reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
- Deutsche Bank sold 8,985 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $165K.
- Deutsche Bank first reported a position in Cellular Biomedicine Group, Inc. in Q1 2015 and held it in 24 quarters.
- Deutsche Bank's Cellular Biomedicine Group, Inc. position peaked at $508K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.
Based on Deutsche Bank's 13F filing for Q1 2021, filed 13 May 2021.